Table 2.
Feature | Missing | All headache | Primary headache | Secondary headache | p value |
---|---|---|---|---|---|
Pain duration >24 h | 21 (13.9%) | 74 (56.9%) | 37 (50.7%) | 37 (64.9%) | 0.104 |
Sudden onset | – | 8 (5.3%) | 2 (2.3%) | 6 (9.4%) | 0.055 |
Side predominance | – | 46 (30.5%) | 34 (39.1%) | 12 (18.8%) | 0.007* |
Throbbing character | 58 (38.4%) | 36 (38.7%) | 24 (44.4%) | 12 (30.8%) | 0.182 |
Subjective pain ≥8/10 | 56 (37.1%) | 33 (34.7%) | 16 (28.1%) | 17 (44.7%) | 0.095 |
Progressive dynamic | 51 (33.8%) | 27 (27.0%) | 11 (19.3%) | 16 (37.2%) | 0.046* |
Any vegetative symptoms | – | 93 (61.6%) | 55 (63.2%) | 38 (59.4%) | 0.631 |
Nausea/Vomiting | – | 81 (53.6%) | 48 (55.2%) | 33 (51.6%) | 0.660 |
Phonophobia | – | 25 (16.6%) | 18 (20.7%) | 7 (10.9%) | 0.111 |
Photophobia | – | 32 (21.2%) | 22 (25.3%) | 10 (15.6%) | 0.151 |
Syncope | – | 9 (6.0%) | 7 (8.0%) | 2 (3.1%) | 0.207 |
Visual disturbancea | – | 48 (31.8%) | 35 (40.2%) | 13 (20.3%) | 0.009* |
Sensory disturbanceb | – | 34 (22.5%) | 27 (31.0%) | 7 (10.9%) | 0.003* |
Language impairment | – | 17 (11.3%) | 12 (13.8%) | 5 (7.8%) | 0.251 |
Vertigo or dizziness | – | 16 (10.6%) | 7 (8.0%) | 9 (14.1%) | 0.235 |
Motoric impairment | – | 10 (6.6%) | 6 (6.9%) | 4 (6.3%) | 0.875 |
Change of consciousness | – | 5 (3.3%) | 1 (1.1%) | 4 (6.3%) | 0.083 |
Seizures | – | 3 (2.0%) | 0 (0.0%) | 3 (4.7%) | 0.041* |
Autonomic symptoms | – | 6 (4.0%) | 3 (3.4%) | 3 (4.7%) | 0.700 |
* = statistical significant (p < 0.05). Subgroup proportions were compared using χ2 test
a = 58.3% scintillating scotoma, 31.3% blurred vision
b = 73.8% unilateral hypoesthesia, 17.6% unilateral paresthesia